Biomet Hip Replacement
About Class Action Litigation and Multi-District Litigation
When corporations or organizations, through their carelessness, harm large groups of individuals, class actions arise. A class action is brought when multiple people suffering the same type of injury sue as a group. The purpose is to eliminate a wrong that has affected a large amount of people by providing a judicial remedy and financial compensation to all members of the class. At Garson Johnson LLC, in Cleveland, Ohio, we have handled multiple class actions and know what needs to be done to secure justice for you.
HIP IMPLANTS
Are you experiencing any of these complications from your hip implant?
- Complex revision surgeries
- Implant dislocation
- Fretting of materials
- Corrosion of materials
- Problems while walking or not being able to walk
- Swelling of your hip
- Infections
- Loosening of the implant within your body
- Bone fracture within the implant site
- High levels of metal toxicity
- Heterotopic ossification (soft tissue becomes calcified)
- Avascular necrosis (bone death)
Is your hip implant one of the following?
- DePuy Orthopaedics- Pinnacle Hip Replacement System
- DePuy Orthopaedics- ASR XL Acetabular System
- DePuy Orthopaedics- ASR Hip Resurfacing System
- Stryker Orthopaedics– Rejuvenate
- Stryker Orthopaedics- ABG II modular-neck hip stems
- Zimmer Holdings- Durom Acetabular Component (Durom Cup)
- Smith & Nephew- R3 Acetabular System
- Biomet- M2a
- Wright Medical- Conserve Plus Total Resurfacing Hip System
- Wright Medical- Profemur Z Hip Stem
You may be entitled to compensation for these recalled or defective hip implants. Call today (216) 696-9330 or complete our hip implant case review form.
BIOMET HIP IMPLANT LAWSUIT
Current litigation against Biomet claims the M2a Magnum hip replacement has caused injuries due to defects in design. The lawsuits are seeking monetary compensation for patients injured by the Biomet hip implant. Biomet hip implant is associated with metal toxicty and failure of the medical device.
Many lawsuits have been filed against Biomet claiming that its M2a Magnum hip implant has caused serious injuries to patients as a result of a design defect. The suits are seeking compensation on behalf of patients injured by the hip implants, which have been linked to metal toxicity and premature failure.
Biomet's M2a Magnum Hip System
Biomedical manufacturer Biomet released the M2a Magnum Hip Replacement System under the assertion of improved stability and greater durability over other hip replacement systems. However, research conducted in the wake of the growing number of injured customers suggests the M2a Magnum Hip Replacement System retains serious risks of premature failure. As of 2014, Biomet paid out more than $55 million in settlements in lieu of the defective nature of the Magnum M2a Hip Replacement Systems. With litigation still pending against Biomet, numerous customers with frictional metallic components have metal shards damaging the surrounding tissues and yet the M2a remains on the open market as a hip replacement option. Customers have faced invasive and daunting corrective surgeries which may only limit suffering rather than correcting the issue in the hip joint itself.
Similar to other metal-on-metal devices, Biomet's Magnum M2a system utilizes a metal ball which is surgically attached to the femoral head which is coupled with an acetabular metal socket. According to the claims against Biomet, over time these metal parts wear when they rub against each other and release metal ions into the hip joint. Symptoms of premature device failure include generally implant failure and even metallosis. Patients experience high levels of cobalt which spawn from the metal-on-metal friction in the implanted Biomet Magnum M2a hip replacement system. The debris and excessive levels of metallic ions present in the patient's body can lead to vertigo, blindness, peripheral neuropathy, optic nerve damage, convulsions, tinnitus, headaches, nausea, vertigo, and even hypothyroidism.
The federal government, specifically the Food and Drug Administration (FDA) convened an advisory panel of health experts in June of 2012 to determine the dangers of metal-on-metal hip replacement systems. The majority of the panel collectively asserted that metal-on-metal devices should most likely not be used on a regular basis due to the high rate of failure. To date, the FDA has not spoken to the prevailing issue regarding the unusually high rate of failure with metal-on-metal devices. These health experts stressed patients experiencing pain or ancillary symptoms of premature device failure of hip replacement implants, such as the Biomet Magnum M2a, should receive routine x-rays and blood testing to measure the levels of metal in their bodies.
In 2012, Biomet subsidiaries collectively settled the consolidated federal litigation against them for an estimated $55 million, thereby awarding each individual plaintiff approximately $205,000. These awards are used to mitigate the damages caused by the defective hip replacement systems released by Biomet. That is to say families have incurred great expenses including hospitalization costs, revisionary surgeries, additional medications, care giving services, general pain and suffering, lost income, punitive damages, and damages to spousal and familial relationships. These devices were marketed to patients who were assured by medical professionals of the Biomet M2a Magnum Hip Replacement System's quality and safety.
You may be entitled to compensation for these recalled or defective hip implants. Call today (216) 696-9330 or complete our hip implant case review form.
